Professional Documents
Culture Documents
Cytology Imaging Segmentation Using The
Cytology Imaging Segmentation Using The
Cytology Imaging Segmentation Using The
1 Introduction
In this paper, we are concerned with the segmentation of medical images. At
present the semi-automatic or automatic analysis of medical images has be-
come a fundamental tool in medicine[2]. For example: high resolution images
of cancer cells can be used to determine the progression of cancer cells mi-
gration, indicating the invasion of cancer cells and cancer metastases [3], and
the count of cells can help to diagnosis diseases [4]. As shown in [5,6,7,8], with
the advancement of the new technologies is more common that hospitals have
new technologies for testing and other assessments. This need for medical tools
has generated a new line of research that include multiple disciplines (doctors,
computer scientists, physicists, etc.) with the objective of effective analysis and
management of biomedical data. The watershed transform is a well-known tool
for segmentation of medical imaging [9,10,11]. The locally constrained watershed
introduced by Beare [1] provides a great flexibility to control how shapes are ex-
tracted. Shape criteria can be added so that the gradient flooding that occurs
P. Soille, M. Pesaresi, and G.K. Ouzounis (Eds.): ISMM 2011, LNCS 6671, pp. 429–438, 2011.
c Springer-Verlag Berlin Heidelberg 2011
430 N. Béliz-Osorio et al.
2 Cytology Imaging
2.1 Pleural Fluid Imaging
A cytology examination of pleural fluid (pleural fluid cytology) is a laboratory
test that detects cancerous cells in the pleural space, the area that surrounds
the lungs [19]. The test is performed by inserting a needle into the pleural space
to draw off a sample of pleural fluid (the procedure is called thoracentesis). The
sample of fluid is examined under the microscope for the presence of abnormal
cells. About 75% of malignant pleural effusions are secondary to lung cancer,
breast cancer and lymphoma. It is estimated that about 50% of patients with
bronchial cancer and 40 to 50% of patients with disseminated breast cancer
have a pleural effusion in the course of its evolution. Pleural metastases can also
cause other primary tumors, such as ovarian carcinomas, sarcomas, melanomas,
cervical cancer, cancers of the digestive tract, bladder, etc.